Ankr

San Francisco, United States Founded: 2022 • Age: 4 yrs
Provider of AI-based cancer symptoms monitoring solutions for patients
Annual revenue - Latest available
Total funding $125,001 1 rounds
Employees 25 Tracked headcount
Investors 1 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Ankr

Ankr is a company based in San Francisco (United States) founded in 2022 by Shivani Rao and Arpit Rao. Ankr has raised $125 thousand across 1 funding round from investors including Y Combinator. The company has 25 employees as of December 31, 2022. Ankr offers products and services including Ankr App, Treatment Navigator, and Medication Tracker. Ankr operates in a competitive market with competitors including Outcomes4Me, Jasper, Vine Health, Osara Health and Navya Network, among others.

  • Headquarter San Francisco, United States
  • Employees 25 as on 31 Dec, 2022
  • Founders Shivani Rao, Arpit Rao
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Ankr Health Corp.
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $125 K (USD)

    in 1 rounds

  • Latest Funding Round
    $125 K (USD), Seed

    Mar 29, 2022

  • Investors
  • Employee Count
    25

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ankr

Ankr offers a comprehensive portfolio of products and services, including Ankr App, Treatment Navigator, and Medication Tracker.

Product name locked
Category locked
Primary

App for AI-driven cancer navigation and side effect management

Product name locked
Category locked
Locked

Tool providing personalized cancer treatment options and warnings

Product name locked
Category locked
Locked

Feature for tracking medications and preventing complications

People of Ankr

Headcount 10-50
Employee Profiles 4
Employee Profiles
People
Arpit Rao
Chief Executive Officer
People
Alexander Colaner
Director Of Sales And Business Development

Unlock access to complete

Funding Insights of Ankr

Ankr has successfully raised a total of $125K through 1 strategic funding round. The most recent funding activity was a Seed round of $125 thousand completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Ankr

Ankr has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage startups are accelerated via funding and educational programs.
Locked Locked Locked
Premium access

Investor details for Ankr

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Ankr

Investments
Premium access

Investment portfolio details for Ankr

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Ankr

Premium access

Detailed financials for Ankr

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ankr Comparisons

Ankr Primary company
Description
Provider of AI-based cancer symptoms monitoring solutions fo...
Location
San Francisco, United States
Founded Year
2022
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
25
As of 2022
Premium access

Peer comparison for Ankr

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Ankr

Ankr operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Outcomes4Me, Jasper, Vine Health, Osara Health and Navya Network, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
App for medical health record for cancer
Locked Locked Locked
Jasper is focused on providing virtual cancer support services.
Locked Locked Locked
Cancer treatment is managed via a social tracking app.
Locked Locked Locked
Osara Health was founded in 2015 in New York.
Locked Locked Locked
Cancer patient education and clinical decision support are provided online.
Locked Locked Locked
A platform is provided to empower cancer patients with information.
Premium access

Detailed competitors of Ankr

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ankr

Premium access

Complete news archive for Ankr

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankr

Ankr was founded in 2022.

Ankr is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Ankr is a funded company, having raised a total of $125K across 1 funding round to date.

As of Dec 31, 2022, the latest employee count at Ankr is 25.

Ankr was founded in 2022 and is based in San Francisco, United States. AI-driven solutions for monitoring cancer symptoms are delivered to patients through mobile and phone-based platforms. Services encompass information delivery, treatment education, medication reminders, symptom tracking, and the sharing of customized data with doctors and caregivers in the health technology sector.

Ankr's top competitors include Outcomes4Me, Mika and Vine Health.

Ankr offers Ankr App, Treatment Navigator, and Medication Tracker.

Ankr has 1 investor. Key investors include Y Combinator.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available